ArticleJournal of experimental & clinical cancer research : CR2025

A combination of PD-1 and TIGIT immune checkpoint inhibitors elicits a strong anti-tumour response in mesothelioma.

Huaikai Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.